Bladder cancer surgery: do stents help or hurt?

NCT ID NCT07655284

First seen Jun 26, 2026 · Last updated Aug 14, 2026 · Updated 3 times

Summary

This study looks at whether using ureteral stents (small tubes) after bladder cancer surgery leads to more or fewer problems than not using them. About 190 adults having their bladder removed will be randomly assigned to get stents or not. The main goal is to see who ends up back in the hospital within 30 days.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ureteral stents (device)
What this could lead to
If this trial succeeds, it could show that skipping stents reduces complications and hospital readmissions after bladder cancer surgery.
What could go wrong
This is a Phase 3 trial, but results may vary by patient and surgical technique. Stents have been standard for years, so not using them could increase leakage or stricture risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLADDER CANCER REQUIRING CYSTECTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Instituto do Câncer do Estado de São Paulo (ICESP)

    São Paulo, São Paulo, 01246-000, Brazil

More trials for these conditions

Other studies related to the condition(s) this trial covers.